The present study is innovative because, to our knowledge, no other study assessed the efficacy of Perindopril in hypertensive patients with endothelial dysfunction by quantifying TSP-1 plasma levels, compared with other antihypertensive drugs such as beta blockers, calcium channel blockers, and diuretics. Here, THBS1 is linked to endothelial dysfunction.